Mouse models of colorectal cancer and liver metastases

被引:90
作者
Heijstek, MW [1 ]
Kranenburg, O [1 ]
Rinkes, IHMB [1 ]
机构
[1] Univ Utrecht, Ctr Med, Dept Surg, NL-3508 GA Utrecht, Netherlands
关键词
colorectal cancer; liver metastases; mouse model; tumor model; optical imaging; small animal imaging;
D O I
10.1159/000085342
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Colorectal cancer ( CRC) is one of the most common malignancies in the western world. Its high mortality rates are particularly related to the occurrence of liver metastases. Many mouse models have been developed to evaluate the various features of CRC in human. Since none of the existing mouse models mimics all the characteristics of human CRC, it is of crucial importance that the optimal model is chosen for each experiment to resolve a specific experimental question. Currently used mouse models for CRC include chemically induced CRC models, genetically engineered mouse models and models in which colon tumors are implanted in recipient mice. Recently, conditional mouse models have been created in which a gene of interest can be ( in) activated in a time- and tissue- specific manner. All models have their advantages and limitations. This review highlights the most commonly used mouse models for CRC and its liver metastases, their usefulness and shortcomings, as well as recent improvements, particularly regarding intravital ( tumor) imaging. Copyright (c) 2005 S. Karger AG, Basel.
引用
收藏
页码:16 / 25
页数:10
相关论文
共 65 条
  • [41] Antimetastatic effect of hepatotropic liposomal adriamycin on human metastatic liver tumors
    Matsuda, I
    Konno, H
    Tanaka, T
    Nakamura, S
    [J]. SURGERY TODAY, 2001, 31 (05) : 414 - 420
  • [42] Mouse models for sporadic cancer
    Meuwissen, R
    Jonkers, J
    Berns, A
    [J]. EXPERIMENTAL CELL RESEARCH, 2001, 264 (01) : 100 - 110
  • [43] Environmental factors as regulators and effectors of multistep carcinogenesis
    Minamoto, T
    Mai, M
    Ronai, Z
    [J]. CARCINOGENESIS, 1999, 20 (04) : 519 - 527
  • [44] MORIKAWA K, 1988, CANCER RES, V48, P1943
  • [45] The potential of 5-fluorocytosine/cytosine deaminase enzyme prodrug gene therapy in an intrahepatic colon cancer model
    Nyati, MK
    Symon, Z
    Kievit, E
    Dornfeld, KJ
    Rynkiewicz, SD
    Ross, BD
    Rehemtulla, A
    Lawrence, TS
    [J]. GENE THERAPY, 2002, 9 (13) : 844 - 849
  • [46] Estimating the world cancer burden: GLOBOCAN 2000
    Parkin, DM
    Bray, F
    Ferlay, J
    Pisani, P
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2001, 94 (02) : 153 - 156
  • [47] Paulsen JE, 2003, ANTICANCER RES, V23, P259
  • [48] Deficient DNA mismatch repair:: a common etiologic factor for colon cancer
    Peltomäki, P
    [J]. HUMAN MOLECULAR GENETICS, 2001, 10 (07) : 735 - 740
  • [49] Pocard M, 1996, IN VIVO, V10, P463
  • [50] Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair
    Prolla, TA
    Baker, SM
    Harris, AC
    Tsao, EL
    Yao, X
    Bronner, CE
    Zheng, BH
    Gordon, M
    Reneker, J
    Arnheim, N
    Shibata, D
    Bradley, A
    Liskay, RM
    [J]. NATURE GENETICS, 1998, 18 (03) : 276 - 279